0
0.5
1
1.5
2+
Mortality
86%
Improvement
Relative Risk
Symp. case
76%
Tixagevimab/c.. PROVENT Prophylaxis DB RCT
Is prophylaxis with tixagevimab/cilgavimab beneficial for COVID-19?
Double-blind RCT 5,172 patients in multiple countries
Fewer symptomatic cases with tixagevimab/cilgavimab (p=0.00046)
c19early.org
Levin et al., Open Forum Infectious Di.., Dec 2021
Favors tixagevimab/ci..
Favors control